Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent

Liang-Jun Yan Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA Abstract: 5-Methoxyindole-2-carboxylic acid (MICA) is a potent hypoglycemic agent that inhibits gluconeogenesis in the liver. It is also a well-kn...

Full description

Bibliographic Details
Main Author: Yan LJ
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/reexploring-5-methoxyindole-2-carboxylic-acid-mica-as-a-potential-anti-peer-reviewed-article-DMSO
_version_ 1797935638135177216
author Yan LJ
author_facet Yan LJ
author_sort Yan LJ
collection DOAJ
description Liang-Jun Yan Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA Abstract: 5-Methoxyindole-2-carboxylic acid (MICA) is a potent hypoglycemic agent that inhibits gluconeogenesis in the liver. It is also a well-known inhibitor of mitochondrial dihydrolipoamide dehydrogenase. MICA was extensively studied in the 1960s and 1970s and was once tested for its antidiabetic effect in diabetic Chinese hamsters, whereby MICA was shown to exhibit pronounced glucose-lowering ability while also leading to increased rate of death of the diabetic animals. Since then, MICA’s potential ability in lowering blood glucose in diabetes has never been revisited. In my opinion, MICA should be comprehensively reexplored for its antidiabetic properties in a variety of rodent diabetes models. For a given animal model, its dose-dependent effect and the effects of different routes of administrations as well as its synergistic effects with other glucose-lowering drugs should also be investigated. More studies in the future on this chemical may provide novel insights into its role as an antidiabetic agent. Keywords: 5-methoxyindole-2-carboxylic acid, antidiabetic, diabetes, dihydrolipoamide dehydrogenase, gluconeogenesis, mitochondria
first_indexed 2024-04-10T18:17:15Z
format Article
id doaj.art-b833a3af5e924b689350ea6d68a25d01
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T18:17:15Z
publishDate 2018-05-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-b833a3af5e924b689350ea6d68a25d012023-02-02T08:30:06ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072018-05-01Volume 1118318638139Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agentYan LJLiang-Jun Yan Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA Abstract: 5-Methoxyindole-2-carboxylic acid (MICA) is a potent hypoglycemic agent that inhibits gluconeogenesis in the liver. It is also a well-known inhibitor of mitochondrial dihydrolipoamide dehydrogenase. MICA was extensively studied in the 1960s and 1970s and was once tested for its antidiabetic effect in diabetic Chinese hamsters, whereby MICA was shown to exhibit pronounced glucose-lowering ability while also leading to increased rate of death of the diabetic animals. Since then, MICA’s potential ability in lowering blood glucose in diabetes has never been revisited. In my opinion, MICA should be comprehensively reexplored for its antidiabetic properties in a variety of rodent diabetes models. For a given animal model, its dose-dependent effect and the effects of different routes of administrations as well as its synergistic effects with other glucose-lowering drugs should also be investigated. More studies in the future on this chemical may provide novel insights into its role as an antidiabetic agent. Keywords: 5-methoxyindole-2-carboxylic acid, antidiabetic, diabetes, dihydrolipoamide dehydrogenase, gluconeogenesis, mitochondriahttps://www.dovepress.com/reexploring-5-methoxyindole-2-carboxylic-acid-mica-as-a-potential-anti-peer-reviewed-article-DMSO5-methoxyindole-2-carboxylic acidanti-diabeticdiabetesdihydrolipoamide dehydrogenasegluconeogenesismitochondria
spellingShingle Yan LJ
Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
Diabetes, Metabolic Syndrome and Obesity
5-methoxyindole-2-carboxylic acid
anti-diabetic
diabetes
dihydrolipoamide dehydrogenase
gluconeogenesis
mitochondria
title Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
title_full Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
title_fullStr Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
title_full_unstemmed Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
title_short Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
title_sort reexploring 5 methoxyindole 2 carboxylic acid mica as a potential antidiabetic agent
topic 5-methoxyindole-2-carboxylic acid
anti-diabetic
diabetes
dihydrolipoamide dehydrogenase
gluconeogenesis
mitochondria
url https://www.dovepress.com/reexploring-5-methoxyindole-2-carboxylic-acid-mica-as-a-potential-anti-peer-reviewed-article-DMSO
work_keys_str_mv AT yanlj reexploring5methoxyindole2carboxylicacidmicaasapotentialantidiabeticagent